Related references
Note: Only part of the references are listed.AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset
David Goertsen et al.
NATURE NEUROSCIENCE (2022)
Adeno-Associated Virus Toolkit to Target Diverse Brain Cells
Rosemary C. Challis et al.
ANNUAL REVIEW OF NEUROSCIENCE (2022)
Development of a low-seroprevalence, avb6 integrin-selective virotherapy based on human adenovirus type 10
Emily A. Bates et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
Aleksei A. Stepanenko et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Human organoids: New strategies and methods for analyzing human development and disease
Nina S. Corsini et al.
CELL (2022)
Fantastic AAV Gene Therapy Vectors and How to Find Them-Random Diversification, Rational Design and Machine Learning
Jonas Becker et al.
PATHOGENS (2022)
The clinical landscape for AAV gene therapies
Dmitry A. Kuzmin et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Enhancer grammar in development, evolution, and disease: dependencies and interplay
Granton A. Jindal et al.
DEVELOPMENTAL CELL (2021)
Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicit
Alicia Teijeira Crespo et al.
IMMUNOLOGY (2021)
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20
James A. Davies et al.
VIRUSES-BASEL (2021)
Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex
John K. Mich et al.
CELL REPORTS (2021)
Engineering adeno-associated virus vectors for gene therapy
Chengwen Li et al.
NATURE REVIEWS GENETICS (2020)
Delivery and Biosafety of Oncolytic Virotherapy
Lizhi Li et al.
FRONTIERS IN ONCOLOGY (2020)
Localized Interleukin-12 for Cancer Immunotherapy
Khue G. Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2020)
Species D Adenoviruses as Oncolytic Viral Vectors
Brianna L. Bullard et al.
VIRUSES-BASEL (2020)
The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier
Juliette Hordeaux et al.
MOLECULAR THERAPY (2019)
Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans
Josephine Juttner et al.
NATURE NEUROSCIENCE (2019)
Cancer modeling meets human organoid technology
David Tuveson et al.
SCIENCE (2019)
A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS)
Ming-Ru Wu et al.
NATURE COMMUNICATIONS (2019)
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
A scalable platform for the development of cell-type-specific viral drivers
Sinisa Hrvatin et al.
ELIFE (2019)
Fighting Cancer with Viruses: Oncolytic Virus Therapy in China
Ding Wei et al.
HUMAN GENE THERAPY (2018)
The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
Wei-Wei Zhang et al.
HUMAN GENE THERAPY (2018)
Designer Oncolytic Adenovirus: Coming of Age
Alexander T. Baker et al.
CANCERS (2018)
Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy
Bita Javan et al.
ECANCERMEDICALSCIENCE (2017)
Adeno-associated virus (AAV) vectors in cancer gene therapy
Jorge L. Santiago-Ortiz et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop
Stacy Robertson et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Benjamin E. Deverman et al.
NATURE BIOTECHNOLOGY (2016)
Pseudotyped βvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies
Hanni Uusi-Kerttula et al.
ONCOTARGET (2016)
Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex
Akiya Watakabe et al.
NEUROSCIENCE RESEARCH (2015)
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
Hanni Uusi-Kerttula et al.
VIRUSES-BASEL (2015)
iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy
C. Puig-Saus et al.
GENE THERAPY (2014)
Retargeting Adenovirus Serotype 48 Fiber Knob Domain by Peptide Incorporation
Lynda Coughlan et al.
HUMAN GENE THERAPY (2014)
Development of a Novel Efficient Method To Construct an Adenovirus Library Displaying Random Peptides on the Fiber Knob
Yuki Yamamoto et al.
MOLECULAR PHARMACEUTICS (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
R. Jude Samulski et al.
ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)
Healing after death: antitumor immunity induced by oncolytic adenoviral therapy
Hong Jiang et al.
ONCOIMMUNOLOGY (2014)
Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction
A. L. Parker et al.
GENE THERAPY (2013)
Displaying High-affinity Ligands on Adeno-associated Viral Vectors Enables Tumor Cell-specific and Safe Gene Transfer
Robert C. Muench et al.
MOLECULAR THERAPY (2013)
Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters
Birgit Dreier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Molecular evolution of human adenoviruses
Christopher M. Robinson et al.
SCIENTIFIC REPORTS (2013)
Transcription factors: from enhancer binding to developmental control
Francois Spitz et al.
NATURE REVIEWS GENETICS (2012)
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson et al.
ADVANCES IN VIROLOGY (2012)
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Hongjie Wang et al.
NATURE MEDICINE (2011)
Transduction and Oncolytic Profile of a Potent Replication-Competent Adenovirus 11p Vector (RCAd11pGFP) in Colon Carcinoma Cells
Jim Silver et al.
PLOS ONE (2011)
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
Dan H. Barouch et al.
VACCINE (2011)
Acquisition of selective antitumoral effects of recombinant adeno-associated virus by genetically inserting tumor-targeting peptides into capsid proteins
Han Saem Lee et al.
ONCOLOGY LETTERS (2011)
Targeting of Adenovirus Serotype 5 Pseudotyped with Short Fiber from Serotype 41 to c-erbB2-Positive Cells using Bispecific Single-Chain Diabody
Elena A. Kashentseva et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer
Alan L. Parker et al.
JOURNAL OF VIROLOGY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
Irene Kuhn et al.
PLOS ONE (2008)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D
Alan L. Parker et al.
JOURNAL OF VIROLOGY (2007)
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
Alan L. Parker et al.
BLOOD (2006)
Identification of sites in adenovirus hexon for foreign peptide incorporation
HJ Wu et al.
JOURNAL OF VIROLOGY (2005)
Enhanced gene transfer activity of peptide-targeted gene-delivery vectors
AL Parker et al.
JOURNAL OF DRUG TARGETING (2005)
The influence of adenovirus fiber structure and function on vector development for gene therapy
SA Nicklin et al.
MOLECULAR THERAPY (2005)
Retargeting of adenoviral infection to melanoma: Combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA
DM Nettelbeck et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates
J Lanciotti et al.
MOLECULAR THERAPY (2003)
Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX
IP Dmitriev et al.
JOURNAL OF VIROLOGY (2002)
In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor
T Smith et al.
MOLECULAR THERAPY (2002)
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses
A Kanerva et al.
MOLECULAR THERAPY (2002)
Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes
H Mizuguchi et al.
GENE (2002)
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors
R Alemany et al.
GENE THERAPY (2001)
Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin
V Krasnykh et al.
JOURNAL OF VIROLOGY (2001)
Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells
JL Jakubczak et al.
JOURNAL OF VIROLOGY (2001)
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
KD Fisher et al.
GENE THERAPY (2001)
A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter
S Koga et al.
HUMAN GENE THERAPY (2000)
Gene therapy -: designer promoters for tumour targeting
DM Nettelbeck et al.
TRENDS IN GENETICS (2000)
Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
